• Home
  • Safety and efficacy of concurrent immune checkpoint inhibitors and hypofractionated body radiotherapy.

Safety and efficacy of concurrent immune checkpoint inhibitors and hypofractionated body radiotherapy.

Author List
Mohamad O, Diaz de Leon A, Schroeder S, Leiker A, Christie A, Zhang-Velten E, Trivedi L, Khan S, Desai NB, Laine A, Albuquerque K, Iyengar P, Arriaga Y, Courtney K, Gerber DE, Hammers H, Choy H, Timmerman R, Brugarolas J, Hannan R
Publication
Oncoimmunology
Publication ID (Profile URL)
https://researcherprofiles.org/profile/71568786
Publication Year
2018
PubMed ID
29900043
Publication Title
Mohamad O, Diaz de Leon A, Schroeder S, Leiker A, Christie A, Zhang-Velten E, Trivedi L, Khan S, Desai NB, Laine A, Albuquerque K, Iyengar P, Arriaga Y, Courtney K, Gerber DE, Hammers H, Choy H, Timmerman R, Brugarolas J, Hannan R. Safety and efficacy of concurrent immune checkpoint inhibitors and hypofractionated body radiotherapy. Oncoimmunology. 2018; 7(7):e1440168.